Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Update of the Recommendations for the Use of Next-Generation Sequencing (NGS) for Patients with Metastatic Cancer

Aired live on 22 Nov 2023

ESMO-Webinar-series-NGS-Metastatic-Cancer-1000x250

Precision Oncology: Genomics Guided Care – Update of the Recommendations for the Use of Next-Generation Sequencing (NGS) for Patients with Metastatic Cancer

Chair: Fabrice André
Speakers: Fernanda Mosele, Benedikt Westphalen

Learning objectives:

  • Discuss the updated and new recommendations for the use of next-generation sequencing (NGS) based on the quick evolvement of precision cancer medicine.
  • Enhance the use of NGS as a high throughput technology in daily practice.
  • Enhance patient's access to NGS and molecular tumour profiling.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.